FindTrial
Sign In

A clinical trial to study the effect of Vitamin D supplements and splint therapy in TMD patients.

Effectiveness of Vitamin D along with Splint therapy in the treatment of Temporomandibular Disorders Patients- A Randomized, double-blind, placebo-controlled clinical trial - none

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028748
Enrollment
40
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M266- Temporomandibular joint disorders

Interventions

Intervention1: â?¢Stabilization occlusal Splint â?¢Vit D capsules : â?¢Stabilization occlusal Splint â?¢Vit D capsules (60000 IU ) ,administered orally, once a week for 8 weeks Control Interventio

Sponsors

Dept Of Prosthodontics Maulana Azad Institute of Dental Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having any of the following symptoms a.Pain or tenderness on palpation of TMJ b.Pain on any type of mandibular jaw movement c.Reduced mandibular opening measured between incisor teeth d.Deviation or deflection of the mandible on opening e.Palpable, audible (stethoscope not used), symptomatic popping, clicking, or crepitations in TMJ mandibular movements 2.Patients who are not relieved by medicinal treatment 3.Vitamin D levels 4.Patients should be fully dentate or at least have sufficient occlusal stops, no more than two posterior teeth missing in each quadrant (excluding third molars).

Exclusion criteria

Exclusion criteria: 1.Completely edentulous patients or patients with no posterior occlusal stops. 2.All anterior teeth missing in either arch. 3.Patients having reduced mouth opening due to TMJ ankylosis. 4.Previous treatment with occlusal appliances. •Patients undergoing Orthodontic treatment. •Patients with periodontally compromised dentition. •Symptoms related to disease in other parts of stomatognathic system. (eg: toothache and neuralgia). •Cervical pain because of cervical spondylitis or any other disease referring to the TMJ region. •Pain because of systemic disease (eg; rheumatoid arthritis, etc) •Patients with acute life-threatening disease. •History of psychiatric disorders/inability to answer a questionnaire for other reasons. •Pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
Reduction in pain in TMJ,Increase in Mouth opening and improvement in Quality of life Timepoint: 1 week,4weeks,8 weeks and 3 months—

Secondary

MeasureTime frame
Decrease in Joint Vibrations assessed by joint vibration analysis ,Improved Vit D levels 30 ng/mlTimepoint: 4 weeks,8 weeks and 3 months—

Countries

India

Contacts

Public ContactDr Abhishek Kumar Gupta

Maulana Azad institute Of Dental Sciences

dr_rekhagupta@yahoo.co.in9654700952

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026